---
search:
  boost: 2 
---

# Nasal Preparations

This is a subcategory of Respiratory Agents.

## Decision Tree

- [Nasal Preparations - NP Criteria - Azelastine / Fluticasone Spray, Beconase AQ, Mometason, Omnaris, Qnasl, Xhance, Zetonna](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNjcxMjRWQTRKTzNXNkJEMUdaVjhBNDJMQyQlQCN0PWcu&topview=Preview)

## Formulary

### Preferred

| Preferred                        | Generic Name                              | Quantity | Time (Days) |
| :------------------------------- | :---------------------------------------- | :------: | :---------: |
| Azelastine                       |                                           |          |             |
| Flunisolide                      |                                           |          |             |
| Fluticasone (Generic of Flonase) |                                           |          |             |
| Ipratropium <sup>QL</sup>        | Ipratropium Bromide Inhalation Soln 0.02% |   1020   |     102     |
| Olopatadine                      |                                           |          |             |

### Non-Preferred

| Non-Preferred                  | Generic Name | Quantity | Time (Days) |
| :----------------------------- | :----------- | :------: | :---------: |
| Azelastine / Fluticasone Spray |              |          |             |
| Beconase AQ                    |              |          |             |
| Budesonide                     |              |          |             |
| Mometasone                     |              |          |             |
| Omnaris                        |              |          |             |
| Qnasl                          |              |          |             |
| Xhance                         |              |          |             |
| Zetonna                        |              |          |             |

## Authorizations

**Length of Authorizations**: 365 days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response to at least **30 days** with at least **two preferred** drugs in the same class, if available
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=98)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=31)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
